2026 Biologics Developability Intern (PhD) jobs in United States
cer-icon
Apply on Employer Site
company-logo

AbbVie · 7 hours ago

2026 Biologics Developability Intern (PhD)

positionWorcester, MA
timeInternship
remoteOnsite
seniorityIntern
money$59K/yr - $100K/yr

AbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. The Biologics CMC Developability group is looking for a PhD intern to assist in sample preparation, data collection, and analysis to support the selection of candidate molecules for progression through the pipeline.

BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Sample preparation, data collection, and data analysis of key molecules
Knowledge of LCMS instrumentation and data analysis is critical
Experience with Oligonucleotide analysis

Qualification

Biologic mass spectrometryLCMS instrumentationOligonucleotide analysisData analysisSample preparation

Required

Currently enrolled in university, pursuing a PhD in Chemistry, Analytical Chemistry, or other related field
Experience in biologic mass spectrometry sample preparation, data collection, and data analysis combined with knowledge of LCMS instrumentation is critical
Experience with oligonucleotide analysis is necessary
Must be enrolled in university for at least one semester following the internship

Preferred

Expected graduation date between December 2026 – June 2027

Benefits

Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time

Company

AbbVie

twittertwittertwitter
Glassdoor3.9
company-logo
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
dateFounded in 2013
location
North Chicago, Illinois, USA
people-size10001+ employees
web-link
https://www.abbvie.com

H1B Sponsorship

AbbVie has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)

Funding

Current Stage
Public Company
Total Funding
$15B
2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO

Leadership Team

leader-logo
Robert Michael
Chairman of the Board and Chief Executive Officer
linkedin
leader-logo
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
linkedin

Recent News

Law.asia
Firms advise on RemeGen’s USD5.6bn AbbVie licensing deal
2026-01-20
FiercePharma
After AbbVie and Genmab's ph. 3 survival miss for Epkinly in DLBCL, what's next?
2026-01-20
The Motley Fool
The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie
2026-01-19
Company data provided by crunchbase